Updated Analysis of Bellini, a Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
Blood (2019) 134 (Supplement_1): 1888.
Currently there are no citedby results. Try again later.
